SCHOLAR ROCK HOLDING CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.53 USD | +4.08% |
|
+4.91% | -22.71% |
| 28/03 | Scholar Rock Shares Rise After Raymond James Initiates Coverage | MT |
| 28/03 | Raymond James Initiates Scholar Rock With Strong Buy Rating, $30 Price Target | MT |
Chart calendar Scholar Rock Holding Corporation
7bb9a3eb56e9aeaaab76515b.t0ht9kjmsLjr-ea7E1Nl0SqPPW2L07at49wjK1hUTZY.-Q07oDqOxuitnIP-RyEmmnv2YluzqeLcga4UYiBnIuPnPh66Ct_y99i2iQ~4809bca3520f07f8eaac7a0ce0df3c9a
Upcoming events on Scholar Rock Holding Corporation
Past events on Scholar Rock Holding Corporation
| 20/03/2024 | BMO Biopharma Spotlight Series |
| 20/03/2024 | BMO Obesity Summit |
| 19/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 12/03/2024 | Jefferies Biotech on the Bay Summit |
| 05/03/2024 07:40 pm | TD Cowen Health Care Conference |
| 06/02/2024 09:00 am | Keystone Symposium - Melissa Fulham |
| 10/01/2024 03:00 am | JPMorgan Healthcare Conference |
| 28/11/2023 11:00 pm | Piper Sandler Healthcare Conference |
| 09/11/2023 09:15 pm | Truist Securities Healthcare Conference |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 07/11/2023 05:45 pm | Q3 2023 Earnings Release |
| 05/11/2023 12:25 am | Society for Immunotherapy of Cancer Meeting - Poster 666 |
| 05/11/2023 12:25 am | Society for Immunotherapy of Cancer Meeting - Poster 726 |
| 05/10/2023 12:00 am | World Muscle Society Congress - Effect of apitegromab on PEDI-CAT and PROMIS-fatigue |
| 05/10/2023 12:00 am | World Muscle Society Congress - Effect of apitegromab on motor function |
| 10/08/2023 01:45 am | Q2 2023 Earnings Release |
| 12/07/2023 06:30 pm | Business Update Call |
| 30/06/2023 08:30 pm | Cure SMA Research & Clinical Care Meeting |
| 30/06/2023 08:10 pm | Cure SMA Research & Clinical Care Meeting |
| 21/06/2023 10:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,5 18,1 13.07% | 15,4 18,2 -15.32% | 18,8 19,2 -1.83% | 33,2 33,2 0.06% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -85,4 -82,4 -3.67% | -127 -133 4.59% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -54,5 -59,6 8.53% | -86,9 -81,5 -6.59% | -130 -133 2.45% | -134 -137 1.95% | -171 -167 -2.44% | -200 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,0 -55,8 8.68% | -86,5 -80,5 -7.48% | -132 -134 1.91% | -135 -138 2.51% | -166 -163 -1.72% | -196 |
|
Net income Million USD | Released Forecast Spread | -51,0 -55,8 8.68% | -86,5 -80,5 -7.45% | -132 -134 1.93% | -135 -138 2.53% | -166 -163 -1.75% | -196 |
|
EPS USD | Released Forecast Spread | -1,85 -2,01 8.14% | -2,81 -2,65 -6.15% | -3,59 -3,67 2.16% | -2,26 -2,28 0.94% | -1,99 -1,99 -0.08% | -2,03 |
| Announcement Date | 12/03/20 | 09/03/21 | 07/03/22 | 07/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,05 4,33 -6.43% | 33,2 19,0 74.98% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -38,4 -43,0 10.81% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -35,4 -38,7 8.51% | -6,93 -22,6 69.38% | -43,1 -39,2 -10.04% | -43,9 -37,9 -15.78% | -40,4 -43,1 6.29% | -40,5 -42,9 5.49% | -39,1 -42,1 7.24% | -43,7 -40,0 -9.31% | -48,0 -44,0 -9.26% | -47,7 | -48,7 | -50,0 | -51,5 | -60,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,9 -38,5 6.6% | -7,95 -22,7 64.98% | -44,0 -39,5 -11.5% | -43,3 -37,8 -14.62% | -39,3 -42,8 8.26% | -39,4 -42,7 7.74% | -37,9 -42,1 9.83% | -42,4 -40,4 -4.8% | -46,1 -43,4 -6.32% | -47,1 | -48,2 | -49,6 | -51,3 | -55,7 |
|
Net income Million USD | Released Forecast Spread | -35,9 -38,5 6.6% | -7,95 -22,7 64.98% | -44,0 -39,5 -11.5% | -43,3 -37,8 -14.62% | -39,3 -42,8 8.26% | -39,4 -42,7 7.74% | -37,9 -42,1 9.83% | -42,4 -40,4 -4.8% | -46,1 -43,4 -6.32% | -47,0 | -48,0 | -49,5 | -51,1 | -55,7 |
|
EPS USD | Released Forecast Spread | -0,97 -1,05 7.19% | -0,21 -0,62 65.99% | -1,06 -1,04 -1.92% | -0,55 -0,69 20.24% | -0,46 -0,57 19.09% | -0,49 -0,57 14.25% | -0,47 -0,56 15.66% | -0,53 -0,52 -1.49% | -0,50 -0,49 -1.41% | -0,51 | -0,51 | -0,52 | -0,50 | -0,54 |
| Announcement Date | 07/03/22 | 16/05/22 | 08/08/22 | 14/11/22 | 07/03/23 | 09/05/23 | 09/08/23 | 07/11/23 | 19/03/24 | - | - | - | - | - |
More events
Past sector events for Scholar Rock Holding Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRRK Stock
- Calendar Scholar Rock Holding Corporation
